Kallmann Syndrome Market was valued at approximately USD 385M in 2025 and is projected to reach nearly USD 670M by 2034, growing at a CAGR of around 6.3%
Kaposi Sarcoma Market was valued at USD 205.0M in 2025 and is projected to reach USD 395.2M by 2034, growing at a CAGR of 7.6% from 2026-2034.
Isolated Cortical Dysplasia Market was valued at USD 1.25B in 2025 and is projected to reach USD 2.45B by 2034, growing at a CAGR of 8.1% from 2026-2034.
Jacobsen Syndrome Market was valued at USD 45.2M in 2025 and is projected to reach USD 158.6M by 2034, growing at a CAGR of 15.1% from 2026-2034.
Jansen Metaphyseal Chondrodysplasia Market was valued at USD 35.0M in 2025 and is projected to reach USD 74.0M by 2034, growing at a CAGR of 8.5% from 2026-2034.
Jervell and Lange-Nielsen Syndrome Market was valued at approximately USD 138M in 2025 and is projected to reach nearly USD 258M by 2034, growing at a CAGR of around 7.2%.
Jeune Syndrome Market was valued at USD 50.2M in 2025 and is projected to reach USD 142.0M by 2034, growing at a CAGR of 12.2% from 2026-2034.
Joubert Syndrome Market was valued at USD 340M in 2025 and is projected to reach USD 685M by 2034, growing at a CAGR of 8.2% from 2026-2034.
Juvenile Dermatomyositis Market was valued at USD 312.6M in 2025 and is projected to reach USD 668.4M by 2034, growing at a CAGR of 8.8% from 2026-2034.
Juvenile Myoclonic Epilepsy Market was valued at USD 1.35B in 2025 and is projected to reach USD 2.48B by 2034, growing at a CAGR of 7.0% from 2026-2034.
Gorham-Stout Syndrome Market was valued at USD 1.8B in 2025 and is projected to reach USD 4.2B by 2034, growing at a CAGR of 8.1%.
Gorlin-Goltz Syndrome Market was valued at USD 125.4M in 2025 and is projected to reach USD 289.6M by 2034, growing at a CAGR of 8.7%.
Griscelli Syndrome Market was valued at USD 245M in 2025 and is projected to reach USD 512M by 2034, growing at a CAGR of 7.4% from 2026-2034.
Guillain-Barré Syndrome Market was valued at USD 767M in 2025 and is projected to reach USD 1.09B by 2034, growing at a CAGR of 5.7% from 2026-2034.
Cri-du-chat Syndrome Market was valued at USD 245M in 2025 and is projected to reach USD 512M by 2034, growing at a CAGR of 7.4% from 2026-2034.
Infantile Neuroaxonal Dystrophy Market was valued at USD 46.8M in 2025 and is projected to reach USD 165.3M by 2034, growing at a CAGR of 15.4% from 2026-2034.
Intracranial Hypertension Market was valued at USD 1.6B in 2025 and is projected to reach USD 3.2B by 2034, growing at a CAGR of 7.9% from 2026-2034.
Iridogoniodysgenesis Market was valued at USD 42.5M in 2025 and is projected to reach USD 118.2M by 2034, growing at a CAGR of 12.0% from 2026-2034.
Isolated Aniridia Market was valued at approximately USD 218M in 2025 and is projected to reach nearly USD 405M by 2034, growing at a CAGR of around 7.2% from 2026-2034.
Goldenhar Syndrome Market was valued at USD 1.2B in 2025 and is projected to reach USD 2.8B by 2034, growing at a CAGR of 8.6% from 2026-2034.
Global Closed Blood Sampling System Market size was valued at USD 1.31 Billion in 2025 and is projected to reach USD 2.68 Billion by 2034, growing at a CAGR of 8.5% from 2025 to 2034 according to a new report by Intellectual Market Insights Research.
Global Blood Pressure Monitors Market was valued at USD 4.2B in 2025 and is projected to reach USD 9.1B by 2034, growing at 8.75% CAGR.
The Infusion Pumps and Accessories Market size is estimated at USD 5.06 Billion in 2025, and is expected to reach USD 8.37 Billion by 2034, growing at a CAGR of 5.02% during the forecast period (2025-2034).
Global Portable Chemotherapy Pump Market size was valued at USD 5.18 Billion in 2025 and is projected to reach USD 8.78 Billion by 2034, growing at a CAGR of 5.8% from 2025 to 2034 according to a new report by Intellectual Market Insights Research.
The global Hutchinson-Gilford Progeria Syndrome market size was valued at USD 118.2 million in 2025 and is projected to reach USD 127.6 million in 2026, expanding to USD 218.4 million by 2034, growing at a CAGR of 6.8% during the forecast period (2026-2034).
The global hydatid cyst market was valued at USD 3.34 billion in 2025 and is projected to reach USD 3.82 billion in 2026, expanding to USD 5.12 billion by 2034, growing at a CAGR of 5.8% during the forecast period (2026-2034).
The global hypereosinophilic syndrome market size was valued at USD 763 million in 2025 and is projected to reach USD 887 million in 2026, expanding to USD 1.96 billion by 2036, growing at a CAGR of 8.68% during the forecast period (2026-2036).
The global hypokalemic periodic paralysis treatment market was valued at USD 1.89 billion in 2025 and is projected to reach USD 2.14 billion in 2026, expanding to USD 4.18 billion by 2034, growing at a CAGR of 8.9% during the forecast period (2026-2034).
It is estimated that the global hypophosphatasia treatment market will grow at 8.5% CAGR in the forecast period to reach USD 1.8 billion by 2034, with approximately USD 997 million worth of sales in 2026.
The global ichthyosis market size was valued at USD 430.5 million in 2025 and is projected to reach USD 460.8 million in 2026, expanding to USD 814.6 million by 2034, growing at a CAGR of 7.4% during the forecast period (2026-2034).
The global immunodeficiencies market size was valued at USD 15.2 billion in 2025 and is projected to reach USD 16.5 billion in 2026, expanding to USD 31.8 billion by 2034, growing at a CAGR of 8.5% during the forecast period (2026-2034).
The global incontinentia pigmenti market was valued at USD 187.3 million in 2025 and is expected to reach USD 200.6 million in 2026, expanding further to USD 345.0 million by 2034, registering a CAGR of 7.1% during the forecast period (2026-2034).
The global infantile myofibrillar myopathy (MFM) market was valued at USD 185.2 million in 2025 and is projected to reach USD 206.5 million in 2026, expanding to USD 492.6 million by 2034, growing at a CAGR of 11.5% during the forecast period (2026-2034).
The global hemophagocytic lymphohistiocytosis (HLH) market was valued at USD 665 million in 2025 and is projected to reach USD 718 million in 2026, expanding to USD 1.32 billion by 2034, growing at a CAGR of 8.1% during the forecast period (2026-2034).
The size of the opsoclonus-myoclonus syndrome global market was valued at US $245 million in 2025 and is forecasted to reach US $264 million by 2026 while growing to US $480 million by 2034 in a CAGR of 7.8% from 2026 to 2034.
The global orofaciodigital syndrome (OFD) market was valued at USD 210 million in 2025 and is expected to grow to USD 227 million in 2026, expanding to USD 420 million by 2034 at a CAGR of 8.0% (2026-2034).
The global market for osteogenesis imperfecta was valued at $1.2 billion in 2025 and is projected to be worth $1.35 billion by 2026, while further growing to $3.0 billion by 2034, at a CAGR of 10.5 percent during the projection period (2026-2034).
The global Pallister-Killian syndrome (PKS) market size was valued at US $108.5 million in 2025 and is expected to reach US $116.8 million in 2026 and is projected to grow to US $214.6 million by 2034, at a CAGR of 8.0% between the forecast period (2026-2034).
The global Pantothenate Kinase-Associated Neurodegeneration (PKAN) market, estimated to be worth $195 million in 2025, is expected to grow to $216 million in 2026 and reach nearly $480 million by 2034, exhibiting a CAGR of 10.5% during the forecast period (2026-2034).
The global hemochromatosis market size was valued at USD 1.3 billion in 2025 and is projected to reach USD 1.4 billion in 2026, expanding to USD 2.6 billion by 2034, growing at a CAGR of 8.1% during the forecast period (2026-2034).
The global hereditary angioedema market size was valued at USD 3.8 billion in 2025 and is projected to reach USD 4.2 billion in 2026, expanding to USD 8.6 billion by 2034, growing at a CAGR of 9.4% during the forecast period (2026-2034).
The global Hermansky-Pudlak syndrome (HPS) market size was valued at USD 148.6 million in 2025 and is projected to reach USD 160.4 million in 2026, expanding to USD 308.0 million by 2034, growing at a CAGR of 8.5% during the forecast period (2026-2034).
The global Hurler syndrome market size was valued at USD 480 million in 2025 and is projected to reach USD 525 million in 2026, expanding to USD 1.08 billion by 2034, growing at a CAGR of 9.4% during the forecast period (2026-2034).
The global Huntington's disease market size was valued at USD 642.7 million in 2025 and is projected to reach USD 868.2 million in 2026, expanding to USD 2,623.4 million by 2034, growing at a CAGR of 17.1% during the forecast period (2026-2034).
Valued at USD 44.8 million in 2025 and expected to grow to USD 48.6 million in 2026, the global Gerstmann-Strussler-Scheinker (GSS) syndrome market is projected to expand to approximately USD 98.3 million by 2034, growing at a CAGR of 9.2% during the forecast period (2026-2034).
The global Gitelman syndrome market was valued at USD 286.4 million in 2025 and is projected to reach USD 309.9 million in 2026, expanding to approximately USD 582.2 million by 2034, growing at a CAGR of 8.2% during the forecast period (2026-2034).
The global Glanzmann thrombasthenia market size was valued at USD 148.2 million in 2025 and is projected to reach USD 160.8 million in 2026, expanding to USD 311.1 million by 2034, growing at a CAGR of 8.6% during the forecast period (2026-2034).
The global Pompe disease market size was valued at USD 1.85 billion in 2025 and is estimated to reach USD 2.05 billion in 2026, expanding to USD 4.48 billion by 2034, growing at a CAGR of 10.2% during the forecast period (2026-2034).
The global Prader-Willi syndrome (PWS) market size was valued at USD 1.5 billion in 2025 and is projected to reach USD 1.65 billion in 2026, expanding to USD 3.4 billion by 2034, growing at a CAGR of 9.5% during the forecast period (2026-2034).
The global progressive supranuclear palsy market was valued at USD 231 million in 2025 and is projected to reach USD 313 million in 2026, expanding to USD 550 million by 2034, growing at a CAGR of 10.4% during the forecast period (2026-2034).
